 Substance Abuse, Intravenous
"Substance Abuse, Intravenous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abuse, overuse, or misuse of a substance by its injection into a vein.
| Descriptor ID |
D015819
|
| MeSH Number(s) |
C25.775.793 F03.900.793
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Substance Abuse, Intravenous".
Below are MeSH descriptors whose meaning is more specific than "Substance Abuse, Intravenous".
This graph shows the total number of publications written about "Substance Abuse, Intravenous" by people in this website by year, and whether "Substance Abuse, Intravenous" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 | | 1996 | 1 | 0 | 1 | | 1998 | 2 | 2 | 4 | | 1999 | 1 | 0 | 1 | | 2000 | 2 | 1 | 3 | | 2001 | 1 | 0 | 1 | | 2002 | 3 | 0 | 3 | | 2003 | 1 | 0 | 1 | | 2004 | 1 | 1 | 2 | | 2005 | 1 | 1 | 2 | | 2006 | 0 | 2 | 2 | | 2007 | 1 | 0 | 1 | | 2008 | 2 | 2 | 4 | | 2009 | 1 | 1 | 2 | | 2011 | 1 | 2 | 3 | | 2012 | 1 | 0 | 1 | | 2013 | 2 | 1 | 3 | | 2014 | 5 | 0 | 5 | | 2015 | 3 | 1 | 4 | | 2016 | 3 | 1 | 4 | | 2017 | 4 | 0 | 4 | | 2018 | 1 | 0 | 1 | | 2019 | 3 | 2 | 5 | | 2020 | 4 | 1 | 5 | | 2021 | 8 | 0 | 8 | | 2022 | 2 | 0 | 2 | | 2023 | 1 | 0 | 1 | | 2024 | 3 | 1 | 4 | | 2025 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Substance Abuse, Intravenous" by people in Profiles.
-
Ganesh SS, Goldshear JL, Wilkins P, Kovalsky E, Simpson KA, Page CJ, Corsi K, Ceasar RC, Barocas JA, Bluthenthal RN. Risk Factors for Infective Endocarditis and Serious Injection Related Infections Among People Who Inject Drugs in Los Angeles, CA and Denver, CO. Drug Alcohol Depend. 2025 Apr 01; 269:112588.
-
Bradley H, Luisi N, Carter A, Pigott TD, Abramovitz D, Allen ST, Asher A, Austin C, Bartholomew TS, Baum M, Board A, Boodram B, Borquez A, Brookmeyer KA, Buchacz K, Burnett J, Cooper HLF, Crepaz N, Debeck K, Feinberg J, Fong C, Freeman E, Furukawa NW, Genberg B, Gorbach P, Hagan H, Hayashi K, Huriaux E, Hurley H, Keruly J, Kristensen K, Lai S, Martin NK, Mateu-Gelabert P, Mcclain GM, Mehta S, Mok WY, Reynoso M, Strathdee S, Torigian N, Weng CA, Westergaard R, Young A, Des Jarlais DC. Assessing coronavirus disease 2019 pandemic impacts on the health of people who inject drugs using a novel data sharing model. AIDS. 2025 Mar 15; 39(4):434-447.
-
Rozansky H, Christine PJ, Younkin M, Fox JM, Weinstein ZM, Suarez S, Stewart J, Farrell N, Taylor JL. Addiction consult service involvement in PrEP and PEP delivery for patients who inject drugs admitted to an urban essential hospital. Addict Sci Clin Pract. 2024 Nov 04; 19(1):77.
-
Krajewski T, LeMasters KH, Oser CB, Brinkley-Rubinstein L. Perceived versus actual HIV risk among PrEP indicated persons with criminal legal involvement. AIDS Care. 2024 Nov; 36(11):1647-1656.
-
Bartholomew TS, Plesons M, Serota DP, Alonso E, Metsch LR, Feaster DJ, Ucha J, Suarez E, Forrest DW, Chueng TA, Ciraldo K, Brooks J, Smith JD, Barocas JA, Tookes HE. Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services. Addict Sci Clin Pract. 2024 03 25; 19(1):21.
-
Miller D, DeHerrera-Smith D, Sharp TA, Gilbert ED. Introducing the Harm Reduction Collaboration Framework for Policy, Systems, and Environmental Change. Health Educ Behav. 2024 06; 51(3):408-415.
-
Bradley H, Austin C, Allen ST, Asher A, Bartholomew TS, Board A, Borquez A, Buchacz K, Carter A, Cooper HLF, Feinberg J, Furukawa N, Genberg B, Gorbach PM, Hagan H, Huriaux E, Hurley H, Luisi N, Martin NK, Rosenberg ES, Strathdee SA, Jarlais DCD. A stakeholder-driven framework for measuring potential change in the health risks of people who inject drugs (PWID) during the COVID-19 pandemic. Int J Drug Policy. 2022 Dec; 110:103889.
-
Wheeler A, Valerio H, Cunningham EB, Martinello M, Barocas JA, Colledge-Frisby S, Treloar C, Amin J, Henderson C, Read P, Matthews GV, Dunlop AJ, Gorton C, Hayllar J, Alavi M, Murray C, Marks P, Silk D, Degenhardt L, Dore GJ, Grebely J. Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study. Drug Alcohol Depend. 2022 08 01; 237:109543.
-
Barocas JA, Eftekhari Yazdi G, Savinkina A, Nolen S, Savitzky C, Samet JH, Englander H, Linas BP. Long-term Infective Endocarditis Mortality Associated With Injection Opioid Use in the United States: A Modeling Study. Clin Infect Dis. 2021 12 06; 73(11):e3661-e3669.
-
Grebely J, Collins AB, Artenie AA, Sutherland R, Meyer JP, Barocas JA, Falade-Nwulia O, Cepeda JA, Cunningham EB, Hajarizadeh B, Lafferty L, Lazarus JV, Bonn M, Marshall AD, Treloar C. Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs. Int J Drug Policy. 2021 10; 96:103469.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|